ÂÜÀòÂÒÂ×

Harry Choi co-founded Molecular Instruments (MI) in 2018, serving as the CEO since its inception. Prior to founding MI, Harry was the lead researcher for three generations of HCR technology development at Caltech (v1.0 in 2010, v2.0 in 2014, v3.0 in 2018), exploiting new concepts from dynamic nucleic acid nanotechnology to overcome multi-decade challenges to multiplexed quantitative bioimaging in thick autofluorescent samples. Harry served as Director of the HCR technology resource within the Beckman Institute at Caltech from 2010–2018, supporting research labs around the world. Harry received a BS in Bioengineering with honors from UC Berkeley and a Ph.D. in Bioengineering from the California Institute of Technology.